Yifan Ma

机构：The University of Texas MD Anderson Cancer Center, Chinese Academy of Sciences, Nantong University, Nankai University, Shanghai Institute of Materia Medica, University of Chinese Academy of Sciences, The University of Tokyo · ORCID：0000-0002-9371-4365

发表论文 285 篇 · 总被引 14001 次 · h-index 60

代表论文

• SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade (2025 · Nature · 被引 108)
• Therapeutic restoration of mitochondria–endoplasmic reticulum cross talk for osteoarthritis (2025 · Proceedings of the National Academy of Sciences · 被引 13)
• Development of an AI-driven digital assistance system for real-time safety evaluation and quality control in laparoscopic liver surgery (2025 · Frontiers in Oncology · 被引 4)
• Injectable and In Situ Hydration‐Reinforced Hybrid Bone Cements for Accelerated Bone Regeneration (2025 · Advanced Science · 被引 3)
• A transferable gut microbiota–bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response (2026 · Nature Materials · 被引 1)
• Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for Duchenne muscular dystrophy (2026 · Nature Biomedical Engineering · 被引 1)